Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Alzheimers Dis ; 12(3): 211-20, 2007 Nov.
Article in English | MEDLINE | ID: mdl-18057553

ABSTRACT

In this study we report that apoptotic death of primary cultures of cerebellar granule neurons is accompanied by release of thioflavin-binding proteins - indicative of the presence of beta-sheet structures - and fibril formation in the culture medium. When the same neurons are subjected to an excytotoxic death caused by 100 microM glutamate exposure, the amount of thioflavin binding is markedly reduced. Western blot analysis shows that fibrils contain monomers, dimers and trimers of amyloid-beta (Abeta) which, when observed at the electron microscope, have morphologies reminiscent of fibrils of senile plaques. These findings demonstrate that triggering an apoptotic pathway leads to beta-sheet transition and fibril formation of a protein primarily involved in Alzheimer's disease and may be of direct relevance to the possible link between apoptosis and this neuropathology.


Subject(s)
Amyloid beta-Protein Precursor/genetics , Apoptosis/physiology , Membrane Proteins/genetics , Microfilament Proteins/genetics , Necrosis/pathology , Reticulin/biosynthesis , Aged , Alzheimer Disease/genetics , Alzheimer Disease/pathology , Benzothiazoles , Cerebellum/pathology , DNA Fragmentation , Enzyme-Linked Immunosorbent Assay , Fluorescent Dyes , Humans , Huntington Disease/genetics , Huntington Disease/pathology , Microscopy, Electron, Transmission , Parkinson Disease/genetics , Parkinson Disease/pathology , Reticulin/ultrastructure , Thiazoles
2.
J Neurochem ; 89(3): 654-9, 2004 May.
Article in English | MEDLINE | ID: mdl-15086522

ABSTRACT

Extracellular signal-regulated kinases such as ERK1 [p44 mitogen-activated protein kinase (MAPK)] and ERK2 (p42 MAPK) are activated in the CNS under physiological and pathological conditions such as ischemia and epilepsy. Here, we studied the activation state of ERK1/2 in rat hippocampal slices during application of the K(+) channel blocker 4-aminopyridine (4AP, 50 micro m), a procedure that enhances synaptic transmission and leads to the appearance of epileptiform activity. Hippocampal slices superfused with 4AP-containing medium exhibited a marked activation of ERK1/2 phosphorylation that peaked within about 20 min. These effects were not accompanied by changes in the activation state of c-Jun N-terminal kinase (JNK), another member of the MAP kinase superfamily. 4AP-induced ERK1/2 activation was inhibited by the voltage-gated Na(+) channel blocker tetrodotoxin (1 micro m). We also found that application of the ERK pathway inhibitors U0126 (50 micro m) or PD98059 (100 micro m) markedly reduced 4AP-induced epileptiform synchronization, thus abolishing ictal discharges in the CA3 area. The effects induced by U0126 or PD98059 were not associated with changes in the amplitude and latency of the field potentials recorded in the CA3 area following electrical stimuli delivered in the dentate hylus. These data demonstrate that activation of ERK1/2 accompanies the appearance of epileptiform activity induced by 4AP and suggest a cause-effect relationship between the ERK pathway and epileptiform synchronization.


Subject(s)
4-Aminopyridine/pharmacology , Epilepsy/chemically induced , Epilepsy/enzymology , Hippocampus/physiopathology , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinases/metabolism , Animals , Electric Stimulation , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Hippocampus/drug effects , In Vitro Techniques , Membrane Potentials/drug effects , Mitogen-Activated Protein Kinase 1/drug effects , Mitogen-Activated Protein Kinase 3 , Mitogen-Activated Protein Kinases/drug effects , Potassium Channel Blockers/pharmacology , Rats , Rats, Wistar , Sodium Channel Blockers/pharmacology
3.
J Neurosci Res ; 75(1): 83-95, 2004 Jan 01.
Article in English | MEDLINE | ID: mdl-14689451

ABSTRACT

Oxidative stress has been implicated in the pathogenesis of stroke, traumatic brain injuries, and neurodegenerative diseases affecting both neuronal and glial cells in the central nervous system (CNS). The tumor suppressor protein p53 plays a pivotal function in neuronal apoptosis triggered by oxidative stress. We investigated the role of p53 and related molecular mechanisms that support oxidative stress-induced apoptosis in glia. For this purpose, we exposed C6 glioma cells and primary cultures of rat cortical astrocytes to an H(2)O(2)-induced oxidative stress protocol followed by a recovery period. We evaluated the effects of pifithrin-alpha (PF-alpha), which has been reported to protect neurons from ischemic insult by specifically inhibiting p53 DNA-binding activity. Strikingly, PF-alpha was unable to prevent oxidative stress-induced astrocyte apoptosis. We demonstrate that p53 is able to mediate an apoptotic response by direct signaling at mitochondria, despite its transcriptional activity. The z-VAD-fmk-sensitive apoptotic response requires a caspase-dependent MDM-2 degradation, leading to p53 mitochondrial targeting accompanied by cytochrome c release and nucleosomal fragmentation.


Subject(s)
Apoptosis/physiology , Astrocytes/metabolism , Nuclear Proteins , Oxidative Stress/physiology , Toluene/analogs & derivatives , Tumor Suppressor Protein p53/physiology , Amino Acid Chloromethyl Ketones/pharmacology , Animals , Apoptosis/genetics , Astrocytes/cytology , Benzothiazoles , Blotting, Northern , Cell Survival , Cells, Cultured , Cytochromes c/metabolism , Embryo, Mammalian , Fluorescent Antibody Technique/methods , Genes, bcl-2/genetics , Hydrogen Peroxide/pharmacology , Microscopy, Confocal/methods , Mitochondria/metabolism , Models, Biological , Neuroprotective Agents/pharmacology , Nucleosomes/metabolism , Oxidants/pharmacology , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-mdm2 , RNA, Messenger/biosynthesis , Rats , Recovery of Function , Reverse Transcriptase Polymerase Chain Reaction/methods , Thiazoles/pharmacology , Time Factors , Toluene/pharmacology , Tumor Suppressor Protein p53/genetics
4.
J Cell Physiol ; 195(1): 27-37, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12599206

ABSTRACT

During ischemia/reperfusion (I/R), cardiomyocytes are exposed to sudden lack of nutrients and successively to radical oxygen species (ROS). In the present study, we used the HL-5 cardiac atrial myocyte cell line exposed to serum/glucose depletion added or not in H(2)O(2) to mimic ROS during ischemia, then replaced in their standard culture medium to simulate reperfusion. We investigated the effects of serum/glucose depletion combined or not to ROS exposure on AKT and MAP kinases activation to address the role of each event with respect to apoptosis. We demonstrate that serum/glucose depletion per se did not induce apoptosis when compared to ROS exposure. In particular, ROS recruited p38MAPK and JNK pathways. SB202190 preventing p38MAPK activity, partially protected HL-5 from apoptosis while blocking JNK, thanks to JNKI, further enhanced apoptosis. Blocking phosphatidylinositol (PI) 3-kinase with LY294002 or ERKs with U0126 was without consequence on apoptosis. Finally, BCL-2 and BCL-X(L/S) expression levels were analyzed in cells exposed to 1 h ischemia followed by 12-h reperfusion in the presence or not of SB202190; BCL-2, but not BCL-X(L/S), expression was decreased in ROS treated cells but SB202190 failed to restore BCL-2 level. Our data suggest that p38MAPK activation primarily mediates ROS-induced apoptosis while concomitant JNK activation would represent a scavenger pathway for cells trying to escape apoptosis.


Subject(s)
Apoptosis/physiology , Myocardial Ischemia/metabolism , Myocytes, Cardiac/drug effects , Oxidative Stress/physiology , Protein Serine-Threonine Kinases , Signal Transduction/physiology , Animals , Apoptosis/drug effects , Cell Line , Enzyme Inhibitors/pharmacology , Flow Cytometry , Hydrogen Peroxide/pharmacology , JNK Mitogen-Activated Protein Kinases , Mice , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinases/metabolism , Myocytes, Cardiac/cytology , Oxidants/pharmacology , Phosphatidylinositol 3-Kinases/metabolism , Phosphoinositide-3 Kinase Inhibitors , Proto-Oncogene Proteins/antagonists & inhibitors , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-akt , Proto-Oncogene Proteins c-bcl-2/metabolism , Reperfusion Injury/metabolism , Signal Transduction/drug effects , Time Factors , bcl-X Protein , p38 Mitogen-Activated Protein Kinases
SELECTION OF CITATIONS
SEARCH DETAIL
...